Skip to main content
Top
Published in: Head & Neck Oncology 1/2011

Open Access 01-12-2011 | Research

Closure of post-laryngectomy pharyngocutaneous fistulae

Authors: Isaac A Bohannon, William R Carroll, J Scott Magnuson, Eben L Rosenthal

Published in: Head & Neck Oncology | Issue 1/2011

Login to get access

Abstract

Background

Closure of salvage laryngectomy defects with vascularized tissue remains controversial.

Methods

We evaluate outcomes in patients who required repair of a fistula after attempted primary closure of salvage laryngectomy defect and assess risk factors for persistent fistula. Between 2001 and 2010, 20 patients were treated for pharyngocutaneous fistulae after primary closure of a salvage laryngectomy. All patients required free flap repair for definitive fistula management.

Results

Patients presented with fistulae from one to 18 months in duration; median time to closure was seven days. Radial forearm free flap was used in 86% of patients. With free flap alone 50% of patients achieved fistula closure. Additional procedures improved closure rate to 85%. Recipient vessels were used in the neck in 54.5%, compared to internal mammary vessels in 45.5%. Hypothyroidism was identified as a risk factor for persistent fistula (p = 0.01). Chronic steroid use (p = 0.08) did not reach significance as a risk factor for fistula closure. Gastroesophageal reflux disease was newly diagnosed or noted as a comorbidity in 14 patients (70%) in this study. It did not reach statistical significance as a risk factor in refistulization (p = 0.12). Complications included leak, carotid blowout, infection, free flap loss, and late refistulization. Overall flap failure in this study was 4.5%.

Conclusions

Delayed secondary repair of pharygocutaneous fistulas after salvage laryngectomy is associated with a higher complication rate and poor success rates compared to use of vascularized tissue at the time of salvage laryngectomy. Prolonged wound healing in these patients is associated with hypothyroidism.
Appendix
Available only for authorised users
Literature
1.
go back to reference Woodard TD, Oplatek A, Petruzzelli GJ: Life after total laryngectomy: a measure of long-term survival function and quality of life. Arch Otolaryngol Head Neck Surg. 2007, 133 (6): 526-532. 10.1001/archotol.133.6.526.CrossRefPubMed Woodard TD, Oplatek A, Petruzzelli GJ: Life after total laryngectomy: a measure of long-term survival function and quality of life. Arch Otolaryngol Head Neck Surg. 2007, 133 (6): 526-532. 10.1001/archotol.133.6.526.CrossRefPubMed
2.
go back to reference Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, Teknos TN, Chepeha DB, Hogikyan ND, Terrell JE, Wolf GT: Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002, 53 (1): 23-28. 10.1016/S0360-3016(02)02712-8.CrossRefPubMed Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, Teknos TN, Chepeha DB, Hogikyan ND, Terrell JE, Wolf GT: Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002, 53 (1): 23-28. 10.1016/S0360-3016(02)02712-8.CrossRefPubMed
3.
go back to reference Hillman RE, Walsh MJ, Wolf GT, Fisher SG, Hong WK: Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol Suppl. 1998, 172: 1-27.PubMed Hillman RE, Walsh MJ, Wolf GT, Fisher SG, Hong WK: Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol Suppl. 1998, 172: 1-27.PubMed
4.
go back to reference Lazarus CL, Logemann JA, Pauloski BR, Colangelo LA, Kahrilas PJ, Mittal BB, Pierce M: Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 1996, 106 (9 Pt 1): 1157-1166.CrossRefPubMed Lazarus CL, Logemann JA, Pauloski BR, Colangelo LA, Kahrilas PJ, Mittal BB, Pierce M: Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 1996, 106 (9 Pt 1): 1157-1166.CrossRefPubMed
5.
go back to reference Dirven R, Swinson BD, Gao K, Clark JR: The assessment of pharyngocutaneous fistula rate in patients treated primarily with definitive radiotherapy followed by salvage surgery of the larynx and hypopharynx. Laryngoscope. 2009, 119 (9): 1691-1695. 10.1002/lary.20521.CrossRefPubMed Dirven R, Swinson BD, Gao K, Clark JR: The assessment of pharyngocutaneous fistula rate in patients treated primarily with definitive radiotherapy followed by salvage surgery of the larynx and hypopharynx. Laryngoscope. 2009, 119 (9): 1691-1695. 10.1002/lary.20521.CrossRefPubMed
6.
go back to reference Johansen LV, Overgaard J, Elbrond O: Pharyngo-cutaneous fistulae after laryngectomy. Influence of previous radiotherapy and prophylactic metronidazole. Cancer. 1988, 61 (4): 673-678. 10.1002/1097-0142(19880215)61:4<673::AID-CNCR2820610410>3.0.CO;2-C.CrossRefPubMed Johansen LV, Overgaard J, Elbrond O: Pharyngo-cutaneous fistulae after laryngectomy. Influence of previous radiotherapy and prophylactic metronidazole. Cancer. 1988, 61 (4): 673-678. 10.1002/1097-0142(19880215)61:4<673::AID-CNCR2820610410>3.0.CO;2-C.CrossRefPubMed
7.
go back to reference Delanian S, Lefaix JL: The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004, 73 (2): 119-131. 10.1016/j.radonc.2004.08.021.CrossRefPubMed Delanian S, Lefaix JL: The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004, 73 (2): 119-131. 10.1016/j.radonc.2004.08.021.CrossRefPubMed
8.
go back to reference Patel UA, Keni SP: Pectoralis myofascial flap during salvage laryngectomy prevents pharyngocutaneous fistula. Otolaryngol Head Neck Surg. 2009, 141 (2): 190-195. 10.1016/j.otohns.2009.03.024.CrossRefPubMed Patel UA, Keni SP: Pectoralis myofascial flap during salvage laryngectomy prevents pharyngocutaneous fistula. Otolaryngol Head Neck Surg. 2009, 141 (2): 190-195. 10.1016/j.otohns.2009.03.024.CrossRefPubMed
9.
go back to reference Withrow KP, Rosenthal EL, Gourin CG, Peters GE, Magnuson JS, Terris DJ, Carroll WW: Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure. Laryngoscope. 2007, 117 (5): 781-784. 10.1097/MLG.0b013e3180332e39.CrossRefPubMed Withrow KP, Rosenthal EL, Gourin CG, Peters GE, Magnuson JS, Terris DJ, Carroll WW: Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure. Laryngoscope. 2007, 117 (5): 781-784. 10.1097/MLG.0b013e3180332e39.CrossRefPubMed
10.
go back to reference Miller MC, Agrawal A: Hypothyroidism in postradiation head and neck cancer patients: incidence, complications, and management. Curr Opin Otolaryngol Head Neck Surg. 2009, 17 (2): 111-115. 10.1097/MOO.0b013e328325a538.CrossRefPubMed Miller MC, Agrawal A: Hypothyroidism in postradiation head and neck cancer patients: incidence, complications, and management. Curr Opin Otolaryngol Head Neck Surg. 2009, 17 (2): 111-115. 10.1097/MOO.0b013e328325a538.CrossRefPubMed
11.
go back to reference Weber RS, Berkey BA, Forastiere A, Cooper J, Maor M, Goepfert H, Morrison W, Glisson B, Trotti A, Ridge JA, Chao KS, Peters G, Lee DJ, Leaf A, Ensley J: Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg. 2003, 129 (1): 44-49. 10.1001/archotol.129.1.44.CrossRefPubMed Weber RS, Berkey BA, Forastiere A, Cooper J, Maor M, Goepfert H, Morrison W, Glisson B, Trotti A, Ridge JA, Chao KS, Peters G, Lee DJ, Leaf A, Ensley J: Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg. 2003, 129 (1): 44-49. 10.1001/archotol.129.1.44.CrossRefPubMed
12.
go back to reference Iteld L, Yu P: Pharyngocutaneous fistula repair after radiotherapy and salvage total laryngectomy. J Reconstr Microsurg. 2007, 23 (6): 339-345. 10.1055/s-2007-992343.CrossRefPubMed Iteld L, Yu P: Pharyngocutaneous fistula repair after radiotherapy and salvage total laryngectomy. J Reconstr Microsurg. 2007, 23 (6): 339-345. 10.1055/s-2007-992343.CrossRefPubMed
13.
go back to reference Gal RL, Gal TJ, Klotch DW, Cantor AB: Risk factors associated with hypothyroidism after laryngectomy. Otolaryngol Head Neck Surg. 2000, 123 (3): 211-217. 10.1067/mhn.2000.107528.CrossRefPubMed Gal RL, Gal TJ, Klotch DW, Cantor AB: Risk factors associated with hypothyroidism after laryngectomy. Otolaryngol Head Neck Surg. 2000, 123 (3): 211-217. 10.1067/mhn.2000.107528.CrossRefPubMed
Metadata
Title
Closure of post-laryngectomy pharyngocutaneous fistulae
Authors
Isaac A Bohannon
William R Carroll
J Scott Magnuson
Eben L Rosenthal
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2011
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-3-29

Other articles of this Issue 1/2011

Head & Neck Oncology 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine